Chad G. Rusthoven, MD, Christine F. Lauro, MD, Brian D

Slides:

Advertisements

Similar presentations

Pulmonary Stereotactic Ablative Radiotherapy:

Advertisements

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.

The Current Role of Operative Venous Thrombectomy in Deep Vein Thrombosis Anthony J. Comerota Seminars in Vascular Surgery Volume 25, Issue 1, Pages 2-12.

Other options in the treatment of fecal incontinence Paul A. Lehur, MD, PhD, Emilie Duchalais, MD Seminars in Colon and Rectal Surgery Volume 27, Issue.

Stage B, a Pre-cursor of Heart Failure Jay N. Cohn, MD, Gary S. Francis, MD Heart Failure Clinics Volume 8, Issue 1, Pages xvii-xviii (January 2012) DOI:

Image Postprocessing in Digital Radiology—A Primer for Technologists Euclid Seeram, RTR, BSc, MSc, FCAMRT, David Seeram Journal of Medical Imaging and.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review David.

Benjamin D. Rosenbluth, M. D. , Victoria Serrano, B. S

Toxicity of Gamma Knife Radiosurgery in the Treatment of Intracranial Tumors in Patients With Collagen Vascular Diseases or Multiple Sclerosis Dot Lowell,

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group Joachim Yahalom,

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute Thomas J. FitzGerald,

Jeffrey Bradley, MD Journal of Thoracic Oncology

Dose–Volume Relationships Associated With Temporal Lobe Radiation Necrosis After Skull Base Proton Beam Therapy Mark W. McDonald, MD, Okechukwu R. Linton,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Evidence-based approach to lumbar disc herniation: Findings from the SPORT trial (primary and subgroup analyses) Ross A. McEntarfer, MD, MS, Christian.

Pain Control by Image-Guided Radiosurgery for Solitary Spinal Metastasis Samuel Ryu, MD, Ryan Jin, MD, Jian-Yue Jin, PhD, Qing Chen, PhD, Jack Rock, MD,

Dosimetric and Economic Comparison of Interstitial High-Dose-Rate Brachytherapy to Stereotactic Body Radiation Therapy for Liver Lesions Brian A. Hrycushko,

Angela Lignelli, MD, Alexander G. Khandji, MD Neurosurgery Clinics

Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer: Rethinking neoadjuvant treatment Matthew C. Biagioli, MD, MS,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Recent Advances in Bronchoscopic Treatment of Peripheral Lung Cancers

Insert tables Insert graphs Insert figure

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

European Urology Oncology

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

The Challenge of Managing Drugs Safely in the Newborn

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer Matthew J. Furman, MD, Giles F. Whalen, MD,

Ashok K. Malani, MD, MS, Brian Olofsson, MD, David Debono, MD

Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)

Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer Nancy El-Bared, MD,

VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure G. Lazzari, A. Terlizzi,

Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned Joe Y. Chang, MD, PhD, Andrea Bezjak,

Heike Döppler, Peter Storz Cell Metabolism

Surgical Management of Brain Metastases

Half-Body Irradiation With Tomotherapy for Pain Palliation in Metastatic Breast Cancer Carlo Furlan, MD, Marco Trovo, MD, Annalisa Drigo, ScD, MPh, Elvira.

Prophylactic Cranial Irradiation (PCI) versus Active MRI Surveillance for Small Cell Lung Cancer: The Case for Equipoise Chad G. Rusthoven, MD, Brian.

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors Shuichi.

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,

Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis William A. Stokes, MD, Brian.

Stereotactic Body Radiotherapy in Patients with Previous Pneumonectomy: Safety and Efficacy Robert Thompson, MD, Meredith Giuliani, MBBS, Mei Ling Yap,

Proton SBRT for Medically Inoperable Stage I NSCLC

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Nicholas Trakul, MD, PhD, Jeremy P

Jeffrey Bradley, MD Journal of Thoracic Oncology

An 18-cm unruptured abdominal aortic aneurysm

Gaurav Marwaha, MD, Kevin L. Stephans, MD, Neil M

Pulmonary Atelectasis after Stereotactic Ablative Radiotherapy for a Central Lung Tumor Sashendra Senthi, MBChB, FRANZCR, Eric F Ullmann, MD, Suresh.

Thomas W. Rice, MD The Journal of Thoracic and Cardiovascular Surgery

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

Neal S Goldstein, MD The Annals of Thoracic Surgery

Technical Innovations and Patient Support in Radiation Oncology

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Skin-directed radiation therapy for palmoplantar pustulosis

Stereotactic Body Radiotherapy for Central Lung Tumors

Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma C. Bondue, S. Racadot,

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT Shuichi.

Presentation transcript:

Stereotactic body radiation therapy (SBRT) for liver metastases: A clinical review Chad G. Rusthoven, MD, Christine F. Lauro, MD, Brian D. Kavanagh, MD, Tracey E. Schefter, MD Seminars in Colon and Rectal Surgery Volume 25, Issue 1, Pages 48-52 (March 2014) DOI: 10.1053/j.scrs.2013.09.009 Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig Axial and coronal images from a representative liver SBRT plan. Legend: A case of stage IV esophageal adenocarcinoma with a large, inoperable liver metastasis (4.1 × 4.5 × 3.4cm3). The red line corresponds to the 100% prescription isodose line (in this case 50Gy delivered in 5 fractions) and conforms tightly to the tumor target volume outlined in black. The yellow line corresponds to the 60% isodose line (in this case 30Gy) demonstrating rapid dose fall-off. The central darker red line represents an intended “hot spot” (in this case 62.5Gy which represents the 125% isodose line) for enhanced cell kill at the tumor's more resistant hypoxic center. Seminars in Colon and Rectal Surgery 2014 25, 48-52DOI: (10.1053/j.scrs.2013.09.009) Copyright © 2014 Elsevier Inc. Terms and Conditions